4.71 USD
+0.04 (+0.86%)
4.75 USD
+0.04 (+0.85%)
ChartMill assigns a Buy % Consensus number of 84% to ABUS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.78. This target is 22.72% above the current price.
ABUS was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ABUS.
In the previous month the buy percentage consensus was at a similar level.
ABUS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-09-05 | Jefferies | Maintains | Buy -> Buy |
| 2024-08-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-03 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-04-04 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-01 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-06-22 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-06-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-29 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-20 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-03 | Chardan Capital | Reiterate | Buy |
ARBUTUS BIOPHARMA CORP / ABUS FAQ
What is the price target for ABUS stock?
9 analysts have analysed ABUS and the average price target is 5.78 USD. This implies a price increase of 22.72% is expected in the next year compared to the current price of 4.71.
How do analysts rate ARBUTUS BIOPHARMA CORP (ABUS)?
The consensus rating for ARBUTUS BIOPHARMA CORP (ABUS) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover ARBUTUS BIOPHARMA CORP (ABUS) stock?
The number of analysts covering ARBUTUS BIOPHARMA CORP (ABUS) is 9.